Erratum to: Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen

By Parekh Chintan   Jubran Rima   Erdreich-Epstein Anat   Panigrahy Ashok   Bluml Stefan   Finlay Jonathan   Dhall Girish  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 681-681

Springer Publishing Company

Access to resources Recommend Favorite

Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option

By Flieger Maya   Ganswindt Ute   Schwarz Silke   Kreth Friedrich-Wilhelm   Tonn Jörg-Christian   Fougère Christian   Ertl Lorenz   Linn Jennifer   Herrlinger Ulrich   Belka Claus   Niyazi Maximilian  

Journal of Neuro-Oncology, Vol. 117, Iss. 2, 2014-04 ,pp. : 337-345

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan

By Zuniga R.   Torcuator R.   Jain R.   Anderson J.   Doyle T.   Ellika S.   Schultz L.   Mikkelsen T.  

Journal of Neuro-Oncology, Vol. 91, Iss. 3, 2009-02 ,pp. : 329-336

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas

By van den Bent M.J.   Schellens J.H.M.   Vecht C.J.   Sillevis Smit P.A.E.   Loosveld O.J.L.   Ma J.   Tijssen C.C.   Jansen R.L.H.   Kros J.M.   Verweij J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1570-1574

Elsevier

Access to resources Recommend Favorite

Incidence and Risk of Thromboembolism During Treatment of High-grade Gliomas: a Prospective Study

By Brandes A.A.   Scelzi E.   Salmistraro G.   Ermani M.   Carollo C.   Berti F.   Zampieri P.   Baiocchi C.   Fiorentino M.V.  

European Journal of Cancer, Vol. 33, Iss. 10, 1997-09 ,pp. : 1592-1596

Elsevier

Access to resources Recommend Favorite